Recombinant HRV 3C Protease

Temporarily not available outside of China.
Content
2000 U Recombinant HRV 3C Protease (lyophilized from 50mM Tris, 150mM NaCl, 1mM EDTA, 1mM DTT, 0.04% Tween20, 8% trehalose, 8% mannitol)
100 μg Cleavage Control Protein (lyophilized from sterile PBS, pH 7.4)
5 ml 10X HRV 3C Cleavage Buffer (1.5 M NaCl, 0.5 M Tris-HCl, pH 7.5)

Description

HRV 3C Protease encoded by human rhinovirus 14 is a highly purified recombinant cysteine protease with a His-tag. Recombinant HRV 3C Protease is a ~20KDa single-chain protein containing approximately 189 amino acids with calculated pI 8.46. HRV 3C protease folds into two anti-parallel six-stranded β-barrels and the site cleft is located at the junction of the two β-barrels domains. The enzyme requires neither metal nor cofactors for activity. It has been demonstrated that the enzyme exhibits highest activity around neutral pH at temperature ranging from 22 to 37℃, even retaining robust activity at 4℃. Thus, cleavage can be performed at low temperature to enhance the stability of the target protein. The catalytic activity is insensitive to organic solvents (up to 10%); however, it can be strongly stimulated by high concentration of anions such as sulfate.

Specificity

The enzyme recognizes the cleavage site:

Leu-Glu-Val-Leu-Phe-Gln-↓-Gly-Pro

Molecular Weight

~22KDa on SDS-PAGE

Storage

Store HRV 3C Protease at –20°C. Store HRV 3C Cleavage Control Protein and Protease Cleavage Buffer at –20°C or 4°C.

Reconstitution

Resuspend the enzyme powder with sterile water. Keep reconstituted enzyme at -20℃ in aliquots. Avoid repeated freeze-thaw cycles.

Lot Number (please refer to the label on vial) Add sterile water for reconstitution
LC12JA2702 550 μ L
LC14MA1914 1600 μ L

Purity

98% by SDS-PAGE.


Quality Control

The purity of each lot is determined by SDS-PAGE. And the activity is ensured by cleavage test with a recombinant fusion protein for each lot. The solution of HRV 3C protease is filtered through 0.22μm sterile filter before package.

Application

The high specificity of HRV 3C protease makes it an ideal tool for cleaving[-0pp;[';p['']']] fusion proteins at definite cleavage sites. The fusion protein can be purified and cleaved by HRV 3C to obtain the target protein. The recombinant HRV 3C protease is easily removed by IMAC Ni-charged resin.

Activity definition

One unit of HRV 3C Protrease is defined as the amount of enzyme that will cleave>95% of 100μg HRV 3C cleavage control protein in 150mM NaCl, 50mM Tris-HCl pH 7.5, at 4℃ for 16h.

User Protocol
Starting conditions

Temperature: 4℃
Incubation time: 16 hours or overnight Enzyme amount: 1:25~1: 100 (U/μg) Empirically, a HRV 3C protease: target protein ratio of 1:25~1: 100 (U/μg) at 4℃ for 16 hours is applicable for most fusion protein cleavage.

Small scale optimization

Due to various properties of fusion proteins, the ratio of HRV 3C protease: target protein, temperature, incubation time is recommended to be optimized for practical application. The following protocol is a simple example to estimate the appropriate amount of the enzyme.

1. Combine 100μg fusion protein, 10μl 10X HRV 3C protease Cleavage Buffer, HRV 3C protease of different volumes and sterile water to make a 100μl total reaction volume. A control sample without HRV 3C protease should be included to detect a possible unspecific cleavage either by autolysis or by proteolytic contaminations of the fusion protein.

Component Volume
enzyme vol.(μl) 0, 0.5, 1, 2
100μg control protein X
10X Cleavage buffer 10
H2O Y
Total volume(μl) 100

2. Incubate the reaction mixture at 4℃ for 16 hours or overnight.

3. Take out 20μl sample and add 20μl 2XSDS-PAGE loading buffer for each treatment and store at -20℃ until SDS-PAGE analysis. If practical, take out aliquots at different time spots to optimize the incubation time.

4. Determine and compare the extent of cleavage of the samples by SDS-PAGE analysis.

If shorter incubation time is required, more amount of HRV 3C protease or higher temperature (RT) can be implemented.

Starting conditions

When the cleavage conditions are optimized at a small scale, scale up the cleavage proportionally according to specific application requirement.
If IMAC Ni-charged resin is used after cleavage to remove the HRV 3C protease, the buffer of target protein should be exchanged into suitable buffers without EDTA or imidazole. Buffer exchange can be carried out by desalting or dialysis.

Fig. The control protein was cleaved by HRV 3C protease at 4°C for 16 h.

Impact of factors on HRV 3C protease activity
Factor Reagent Concentration Relative
Activity (%)
Salt NaCl 0.8M 150
0.2M 110
2.5-3M 200
ZnCl2 0.2mM 0
Na2SO4 0.8M 1570~7200
Protease inhibitor EDTA 50mM 100
EGTA 50mM 100
Egg White cystatin 8μm 100
E-64 100μm 100
Iodoacetamide 1.0±0.1mM 50
Pepstatin 20μm 100
Aprotinin 15μm 100
Benzamidine 50mM 100
Leupeptin 0.75±0.05mM 50
PMSF 8.0±0.2mM 5 50
TLCK >1.0mM 50
Denaturant Urea 3M 0
2M 0
1M 40
Guanadine 3M 0
2M 0
1M 0
Reductant DTT 1mM 100
Detergent Triton X-100 0.10% >100
1% 100
Tween 20 0.10% >100
1% 100
Nonidet P-40 0.10% >100
1% 100
Anion(Na salt) F- 0.2M 250
0.4M 470
Cl- 0.2M 110
0.4M 130
0.8M 150
Br- 0.2M 90
0.4M 85
0.8M 81
I- 0.2M 81
0.4M 63
0.8M 54
CH3CO2- 0.2M 150
0.4M 181
0.8M 338
SO32- 0.2M 122
0.4M 220
0.8M 365
SO42- 0.2M 252
0.4M 680
0.8M 1570
1M 2200
Co-solvent Acetonitrile 10% 48
DMSO 10% 74
Isopropanol 10% 74
Methanol 10% 91
Glycerol 10% 114
Etylene glycol 10% 95
PEG-3400 10% 90
Sorbitol 10% 120
Sucrose 10% 112
Elute buffer Imidazole 20~250mM 100

References

[1] Cordingley, M. G., Register, R. B., Callahan, P. L., Garsky, V.M., and Colonno, R. J. (1989) Cleavage of Small Peptides In Vitro by Human Rhinovirus 14 3C Protease Expressed in Escherichia coli. J. Virol. 63, 5037-5045

[2] Q.May Wang and Shu-Hui Chen. (2007) Human Rhinovirus 3C Protease as a Potential Target for the Development of Antiviral Agents. Current Protein and Peptide Science, 8: 18-27

[3] Matthews, D.A., Smith, W.A., Ferre, R.A., Codon, B., Budahazi,G., Sisson, W., Villafranca, J.E., Janson, C.A., McElroy, H.E.,Gribskov, C.L. and Worland S. (1994) Structure of Human Rhinovirus 3C Protease Reveals a Trypsin-like Polypeptide Fold, RNA-Binding Site, and Means for Cleaving Precursor Polyprotein. Cell, 77, 761-771.

[4] Q. May Wang, Robert B. Johnson. (2001) Activation of Human Rhinovirus-14 3C Protease. Virology 280, 80-86

  • AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B
    Author
    Johanns, M;Lai, YC;Hsu, MF;Jacobs, R;Vertommen, D;Van Sande, J;Dumont, JE;Woods, A;Carling, D;Hue, L;Viollet, B;Foretz, M;Rider, MH;
    Year
    2016
    Journal
    Nat Commun
    Application
    enzyme
  • Direct interaction of the resistance to inhibitors of cholinesterase type 3 protein with the serotonin receptor type 3A intracellular domain
    Author
    Nishtala, SN;Mnatsakanyan, N;Pandhare, A;Leung, C;Jansen, M;
    Year
    2016
    Journal
    J. Neurochem.
    Application
    enzyme
  • High-level expression and purification of the major house dust mite allergen Der p 2 in Escherichia coli
    Author
    Cao, T;Zhang, Z;Liu, ZG;Dou, X;Zhang, J;Zhang, W;Wu, B;Yu, ZD;Wei, Z;Yu, B;
    Year
    2016
    Journal
    Protein Expr. Purif.
    Application
    enzyme
  • Production of Chemokine/Chemokine Receptor Complexes for Structural Biophysical Studies
    Author
    Gustavsson, M;Zheng, Y;Handel, TM;
    Year
    2016
    Journal
    Meth. Enzymol.
    Application
    enzyme
  • Purification of a polyclonal antibody against CD147 for ELISA using antigen-immunoaffinity chromatography
    Author
    LIU, S;LI, S;ZHANG, Y;WANG, Y;ZHU, Y;WANG, B;CHEN, Z;
    Year
    2017
    Journal
    MOLECULAR MEDICINE REPORTS
    Application
    Enzyme
  • Identification of quinone analogues as potential inhibitors of picornavirus 3C protease in vitro
    Author
    Jung, E;Lee, J;Kim, H;Ryu, C;Lee, K;Kim, M;Lee, C;Go, Y;
    Year
    2018
    Journal
    Bioorganic & Medicinal Chemistry Letters
    Application
    enzyme
  • Rhinovirus 3C protease suppresses apoptosis and triggers caspase-independent cell death
    Author
    Lötzerich, M;Roulin, PS;Boucke, K;Witte, R;Georgiev, O;Greber, UF;
    Year
    2018
    Journal
    Cell Death Dis
    Application
    Enzyme
  • The intrinsically disordered C-terminal F domain of the ecdysteroid receptor from Aedes aegypti exhibits metal ion-binding ability
    Author
    Więch, A;Rowińska-Żyrek, M;Wątły, J;Czarnota, A;Hołubowicz, R;Szewczuk, Z;Ożyhar, A;Orłowski, M;
    Year
    2018
    Journal
    J. Steroid Biochem. Mol. Biol.
    Application
    enzyme
カートに追加しました カートに追加しませんでした カートを更新しています。少々お待ちください U.S.A.